# Sonoma Pharmaceuticals, Inc.: filings

SNOA · Nasdaq · CIK 1367083 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/snoa.md) · [Financials](/companies/snoa/financials.md) · [Filings](/companies/snoa/filings.md) · [Insiders](/companies/snoa/insiders.md)

## Reports and events: 326 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 253, 8-K 198, 10-Q 53, 424B5 34, CORRESP 34, DEF 14A 23, UPLOAD 22, 10-K 18, 3 17, 424B3 17, DEFA14A 17, CT ORDER 15, S-8 15, EFFECT 14, S-1/A 13, PRE 14A 8, SC 13G/A 8, SC 13G 7, POS AM 6, S-1 6, S-3 6, S-3/A 6, 10-Q/A 5, 144 4, 424B2 4, 8-K/A 4, NT 10-Q 4, SC 13D 4, NT 10-K 3, 144/A 2, 424B4 2, 8-A12B 2, REGDEX 2, SC 13D/A 2, 25-NSE 1, 8-A12B/A 1, AW 1, CERTNAS 1, DRS 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 20:30 ET | [8-K](/filings/0001683168-26-007657.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001683168-26-007657 |
| 2026-09-17 | 22:11 ET | [8-K](/filings/0001683168-26-007199.md) | 5.07 Shareholder vote results | 0001683168-26-007199 |
| 2026-08-19 | 21:27 ET | [8-K](/filings/0001683168-26-006608.md) | 5.07 Shareholder vote results | 0001683168-26-006608 |
| 2026-08-06 | 12:30 ET | [10-Q](/filings/0001683168-26-006024.md) | Quarterly report, period 2026-06-30 | 0001683168-26-006024 |
| 2026-07-28 | 20:50 ET | [DEF 14A](/filings/0001683168-26-005810.md) | Proxy statement, period 2026-09-16 | 0001683168-26-005810 |
| 2026-06-18 | 20:33 ET | [8-K](/filings/0001683168-26-004975.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-004975 |
| 2026-06-16 | 20:02 ET | [10-K](/filings/0001683168-26-004871.md) | Annual report, period 2026-03-31 | 0001683168-26-004871 |
| 2026-05-05 | 20:55 ET | [DEF 14A](/filings/0001683168-26-003495.md) | Proxy statement, period 2026-06-24 | 0001683168-26-003495 |
| 2026-04-30 | 21:00 ET | [8-K](/filings/0001683168-26-003381.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-003381 |
| 2026-04-23 | 00:07 ET | [S-1/A](/filings/0001683168-26-003139.md) | Registration statement, amended | 0001683168-26-003139 |
| 2026-04-17 | 21:23 ET | [S-1](/filings/0001683168-26-003052.md) | Registration statement | 0001683168-26-003052 |
| 2026-04-09 | 12:30 ET | [8-K](/filings/0001683168-26-002761.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-26-002761 |
| 2026-02-10 | 21:01 ET | [10-Q](/filings/0001683168-26-000889.md) | Quarterly report, period 2025-12-31 | 0001683168-26-000889 |
| 2026-01-28 | 21:01 ET | [8-K](/filings/0001683168-26-000589.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-26-000589 |
| 2026-01-12 | 13:30 ET | [8-K](/filings/0001683168-26-000205.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-000205 |
| 2026-01-02 | 22:18 ET | [8-K](/filings/0001683168-26-000027.md) | 5.02 Departure or appointment of officers or directors | 0001683168-26-000027 |
| 2025-11-04 | 13:46 ET | [10-Q](/filings/0001683168-25-007938.md) | Quarterly report, period 2025-09-30 | 0001683168-25-007938 |
| 2025-10-23 | 21:00 ET | [8-K](/filings/0001683168-25-007750.md) | 5.02 Departure or appointment of officers or directors | 0001683168-25-007750 |
| 2025-10-09 | 20:30 ET | [8-K](/filings/0001683168-25-007478.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-25-007478 |
| 2025-09-29 | 20:30 ET | [8-K](/filings/0001683168-25-007307.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-007307 |
| 2025-09-26 | 21:01 ET | [8-K](/filings/0001683168-25-007265.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-25-007265 |
| 2025-08-29 | 20:37 ET | [8-K](/filings/0001683168-25-006580.md) | 5.07 Shareholder vote results | 0001683168-25-006580 |
| 2025-08-07 | 20:02 ET | [10-Q](/filings/0001683168-25-005753.md) | Quarterly report, period 2025-06-30 | 0001683168-25-005753 |
| 2025-07-11 | 20:15 ET | [DEF 14A](/filings/0001683168-25-005049.md) | Proxy statement, period 2025-08-27 | 0001683168-25-005049 |
| 2025-06-17 | 20:01 ET | [10-K](/filings/0001683168-25-004546.md) | Annual report, period 2025-03-31 | 0001683168-25-004546 |
| 2025-04-28 | 12:30 ET | [8-K](/filings/0001683168-25-002874.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-002874 |
| 2025-04-07 | 12:30 ET | [8-K](/filings/0001683168-25-002294.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-002294 |
| 2025-03-25 | 20:01 ET | [8-K](/filings/0001683168-25-001857.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-25-001857 |
| 2025-02-05 | 21:01 ET | [10-Q](/filings/0001683168-25-000736.md) | Quarterly report, period 2024-12-31 | 0001683168-25-000736 |
| 2025-01-30 | 21:01 ET | [8-K](/filings/0001683168-25-000611.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-25-000611 |
| 2025-01-03 | 22:00 ET | [8-K](/filings/0001683168-25-000076.md) | 5.02 Departure or appointment of officers or directors | 0001683168-25-000076 |
| 2024-11-21 | 21:01 ET | [8-K](/filings/0001683168-24-008332.md) | 1.02 Termination of a material agreement | 0001683168-24-008332 |
| 2024-11-07 | 13:36 ET | [10-Q](/filings/0001683168-24-007708.md) | Quarterly report, period 2024-09-30 | 0001683168-24-007708 |
| 2024-10-22 | 12:30 ET | [8-K](/filings/0001683168-24-007283.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-007283 |
| 2024-09-20 | 10:02 ET | [8-K](/filings/0001683168-24-006556.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-006556 |
| 2024-08-28 | 10:03 ET | [8-K](/filings/0001683168-24-006053.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-006053 |
| 2024-08-23 | 22:08 ET | [8-K](/filings/0001683168-24-005980.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-005980 |
| 2024-08-21 | 12:30 ET | [8-K](/filings/0001683168-24-005938.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-24-005938 |
| 2024-08-08 | 20:01 ET | [10-Q](/filings/0001683168-24-005371.md) | Quarterly report, period 2024-06-30 | 0001683168-24-005371 |
| 2024-07-01 | 11:30 ET | [DEF 14A](/filings/0001683168-24-004552.md) | Proxy statement, period 2024-08-14 | 0001683168-24-004552 |
| 2024-06-27 | 11:31 ET | [8-K](/filings/0001683168-24-004506.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-004506 |
| 2024-06-17 | 20:13 ET | [10-K](/filings/0001683168-24-004275.md) | Annual report, period 2024-03-31 | 0001683168-24-004275 |
| 2024-04-09 | 11:30 ET | [8-K](/filings/0001683168-24-002224.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-002224 |
| 2024-04-02 | 11:30 ET | [8-K](/filings/0001683168-24-002051.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-002051 |
| 2024-03-22 | 20:30 ET | [8-K](/filings/0001683168-24-001635.md) | 3.01 Delisting notice | 0001683168-24-001635 |
| 2024-03-08 | 21:29 ET | [8-K](/filings/0001683168-24-001399.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-24-001399 |
| 2024-02-08 | 21:01 ET | [10-Q](/filings/0001683168-24-000781.md) | Quarterly report, period 2023-12-31 | 0001683168-24-000781 |
| 2024-01-10 | 12:30 ET | [8-K](/filings/0001683168-24-000168.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-000168 |
| 2024-01-09 | 21:47 ET | [8-K](/filings/0001683168-24-000150.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-24-000150 |
| 2023-12-29 | 22:23 ET | [8-K](/filings/0001683168-23-009150.md) | 5.02 Departure or appointment of officers or directors | 0001683168-23-009150 |

Page 1 of 7. [Older](/companies/snoa/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.